Comparison of Ayurvedic drugs in the treatment of childhood asthma

Clinical efficacy of Tejovatyadi ghrta and Kushmanda Rasayana in Tamaka shwasa w.s.r to Childhood Asthma - A Comparative Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/041111

Enrollment

Registered

2022-03-15

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients presented with classical signs and symptoms of mild Tamaka shwasa. Shwasa, Kasa, Gurgurka, Kaphnisteevana, Ateeva teevra vega shwasa. Age group 05-16 years. Sex - Both Male and Female Parents who will give consent to participate in the study

Exclusion criteria

Exclusion criteria: Age below 5 and above 16 years. Children with asadya lakshanas of Tamaka shwasa. Children associated with other chronic diseases and high-risk diseases like hepatic disorders, tuberculosis, nephrotic syndrome, cardiac diseases, diabetes mellitus and other systematic diseases.

Design outcomes

Primary

Measure	Time frame
clinical symptoms like cough dyspnea wheeze will be improved and will be assessed by peak expiratory flow rate and absolute eosinophil countTimepoint: results are expected in 45 to 60 days	—

Secondary

Measure	Time frame
symptoms like sputum expectoration paroxysm dyspnea will be reduced assessed by peak expiratory flow rate and absolute eosinophil countTimepoint: results are expected in 60 days	—

Countries

India

Contacts

Public ContactDR ABHINAV KUMAR

VAIDYA YAGYA DUTT SHARMA PG AYURVEDIC COLLEGE

chaitu.k1589@gmail.com9966948637

Outcome results